在线观看人与动牲交视频_夜夜高潮次次欢爽AV女_奇米在线视频观看_欧美精品七区_色悠久久综合网_少妇潮喷无码白浆水视频

美國 愛爾康公司 (Alcon Laboratories, Inc.)   
愛爾康公司 (Alcon Laboratories, Inc.) 成立于1947年，是全球最大的眼科藥品與醫療器械專業公司。在全球75個國家和地區設有分公司，擁有15,000多名員工，5 個研發中心，14個生產工廠，產品銷售遍及180多個國家和地區。愛爾康公司全面研發、生產、營銷眼部醫藥品、眼科手術設備裝置、隱形眼鏡相關護理產品和其他治療疾病、調節不適的眼部護理消費品。除了沒有開展生產銷售眼鏡及隱形眼鏡產品的業務以外，愛爾康涉足了眼科學產品的所有領域。

愛爾康公司高層管理人員敏銳的洞察力和雀巢公司堅定不移的支持，愛爾康公司一直保持其在眼科市場上的領先地位及在全球范圍內飛快的發展速度。2008年銷售額已超過了63億美元，遙居同行業榜首。在未來的5年中，愛爾康計劃在研發方面投資30億美元，公司確信這將是眼科領域最大的科研投資。此外，愛爾康公司在美國《財富》雜志“100個最值得工作的公司”年度調查中連續數年榜上有名。

雖然公司主要關注于提供治療眼部疾病與不適癥狀的最佳產品與方案，愛爾康同時還致力于減少全球可預防性失明。在過去的3年里，愛爾康在全球范圍內捐贈了1.36億美元現金與產品用于慈善活動，其中包括低收入患者援助項目以及對1200個醫療任務進行贊助，從而幫助那些沒有條件治療眼部疾病的人恢復視力。愛爾康在72個國家設有醫師培訓中心，能夠提供最新的眼部護理技術持續培訓，其中大部分培訓中心都設在新興市場。此外，愛爾康還努力減輕生產對環境所造成的影響，大力開展諸如產品返回與回收、材料聲明、生命周期分析及產品監管等項目。

愛爾康（中國）眼科產品有限公司是美國愛爾康公司于1995年在中國設立的獨資公司，目前擁有500多名員工和9個辦事處，產品銷售遍及全國各地，包括新疆，西藏等邊遠地區。愛爾康（中國）眼科產品有限公司作為愛爾康大家庭的一員，在過去的十幾年間，秉承了愛爾康公司的一貫宗旨，為推動中國眼科事業的發展做出了不懈的努力。愛爾康(中國)眼科產品有限公司將牢記對眼科醫生和患者的承諾，加強與中國眼科專家的合作，攜手共創輝煌的明天。

愛爾康（中國）同中華醫學會眼科學分會緊密合作，舉辦各種規模各種類型的學術研討會，全國眼科年會，以及國際眼科會議，為國內眼科醫生的學術交流活動創造搭建平臺，為推動中國眼科事業的發展做出不懈的努力。同時愛爾康（中國）還同中國殘聯，健康快車等慈善機構的合作，支持各種扶貧項目，為中國的防盲治盲工作貢獻力量。
 
Founded in 1945, Alcon Laboratories, Inc. traces its roots back to two pharmacists, Robert Alexander and William Conner, who opened a small pharmacy in Fort Worth, Texas, and combined the first syllables of their last names to create the name Alcon.

Majority owned by Nestlé S.A. and incorporated in Hünenberg, Switzerland with U.S. operations based in Fort Worth, Texas, our team of over 15,000 dedicated employees worldwide develops, manufactures, and distributes hundreds of eye care products in more than 180 countries. This seasoned and diverse group of people, who encircle the globe, are united by a common mission: to make Alcon the most trusted eye care company worldwide and the first choice of eye care professionals and their patients.

In March 2002, Alcon conducted a partial initial public offering (IPO) on the New York Stock Exchange (NYSE). Nestlé still owns approximately 75 percent of the company.

Alcon's core business is centered on three key divisions – Surgical, Pharmaceutical and Consumer Vision Care. As of 2008, sales reached US$6.3 billion.

We conduct our business from Alcon offices located in 75 countries around the world in regions including Canada and the Far East; Europe, Middle East and Africa; Latin America and the Caribbean; and the United States.

People
Although the average tenure of Alcon employees is just nine years, it is not uncommon to find people who have worked for Alcon for 25 years or more. The dedication and commitment is contagious – often when people arrive, they see no reason to leave. Instead, they see several reasons to stay. Alcon employees are constantly being challenged and rewarded for excellence. It's easy to be proud of who we are and what we do. More importantly, it's easy to be proud of how we do it. We don't just enhance, preserve and restore vision; we foster an Alcon family of nearly 15,000, around the world who dedicate themselves to this same mission.

Learn more about the people who make Alcon successful.

Corporate Responsibility
Community & Humanitarian Involvement
We recognize we offer what many people need, whether or not they can afford it or even know it exists. As a result, a significant part of our culture revolves around our responsibility to the community and to humanity as a whole. Many of our charitable endeavors involve services for, and support of, the communities in which we operate and live. We also offer a patient assistance program to assist those in need of our therapies but who lack the resources to pay for them.

In 2008 our Medical Missions Program donated US$55 million in cash and products to charitable activities, including patient access assistance programs for low income patients and 1,200 medical missions in more than 90 countries that restore vision to those without access to eye care services. As part of these missions, we partner with physicians and humanitarian organizations such as the ORBIS "Saving Sight Worldwide" Program and Mercy Ships. Additionally, we established The Alcon Foundation, Inc. to support the philanthropic interests of Alcon that include research efforts and organizations in the field of eye care with special consideration given to those programs that advance the education and skill levels of eye care professionals. The Foundation also supports leadership programs, education and the arts in the communities in which we operate.

Learn more about Alcon's involvement in the community and with humanitarian organizations around the world.

Commitment to Quality
We consider quality to be much more than simple conformance to product or program specifications and requirements. We seek to continually improve all aspects of our business processes and quality management systems. We strive to comply with the highest level of regulatory and statutory requirements, and we consistently meet or exceed these standards in each market. And we recognize that the global market can be a complicated one with local controls and requirements. As a global company, we are diligent in ensuring compliance in each of our global markets.

Learn more about Alcon's commitment to quality.

Research & Development
Alcon's R&D organization is the largest of its kind in the world consisting of more than 1,350 employees, including approximately 300 individuals who are M.D.s, O.D.s or Ph.D.s. Our researchers, scientists and engineers work in one of five state-of-the-art research facilities in the U.S., Spain and Switzerland and partner with leading academic institutions, other healthcare companies and individual physicians to ensure that our products are among the best in eye health.

Learn more about Alcon's research and development efforts.

Business Focus
Alcon's core business is centered on three key divisions – Surgical, Pharmaceutical and Consumer Vision Care.

Surgical
Alcon offers the industry's most comprehensive portfolio of ophthalmic surgical products, enabling surgeons to achieve optimal results for their patients. As the worldwide leader in ophthalmic surgical products, Alcon occupies the premier position in surgical suites across the globe and manufactures and markets products for all ocular surgical procedures. As the developer and manufacturer of the worlds' most preferred line of intraocular lenses, AcrySof?, which is implanted globally in 60 percent of all cataract patients, Alcon is redefining vision for